Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. - Wikidata - awgldk - TriplyDB

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

http://www.wikidata.org/entity/Q34213612

about

Patient Participation and the Use of Ehealth Tools for Pharmacoviligance Legal and regulatory considerations associated with use of patient-generated health data from social media and mobile health (mHealth) devices The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective.The value of patient reporting to the pharmacovigilance system: a systematic review.Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US.What can we learn from parents about enhancing participation in pharmacovigilance?The Impact of Experiencing Adverse Drug Reactions on the Patient's Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands.Experiences with adverse drug reaction reporting by patients: an 11-country survey.Adverse drug reaction reporting by patients: an overview of fifty countries.ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.Factors affecting patient reporting of adverse drug reactions: a systematic review.Patients' motives for participating in active post-marketing surveillance.Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.Public confidence in ADR identification and their views on ADRreporting: mixed methods study.Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.Filtering Entities to Optimize Identification of Adverse Drug Reaction From Social Media: How Can the Number of Words Between Entities in the Messages Help?Feedback for patients reporting adverse drug reactions; satisfaction and expectations.Survey of patients' experiences and their certainty of suspected adverse drug reactions.Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.Pharmacovigilance for a revolving world: prospects of patient-generated data on the internet.A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.Social media and networks in pharmacovigilance: boon or bane?

P2860

Q26752684-D20FD0CE-78D4-453A-9EE8-968356C3AEE2 Q30925041-22D5B633-0592-48CB-B78D-84736FF38CFD Q33845548-E90D7596-3161-459C-B301-E883FB0AC607 Q35624610-F3EA5581-02DD-4CFD-BA6D-655205EE8DF2 Q36112324-DFBCE4AD-7137-4416-B81E-C4B0ECAB1CBA Q36309300-94F1654D-7663-4E31-84A5-0DD38472E50F Q36729977-D2BC9FEC-65DF-4D11-9AD0-2FD2FFE671C0 Q37067136-AD1A0DEF-1A16-4292-9DB3-0BF5AAA2FF3D Q37965625-691B0227-A552-4A23-A5A6-C4DEE599734F Q38205725-BA820ECE-9934-4707-B123-C3E64D1A0140 Q38334927-F9E755F5-9ABB-45B7-9B0B-6AAB0A11AE09 Q39015017-3C570DC0-10CB-4BFA-91CF-17DB7D69DDAC Q39579049-6E53F2D2-DBC3-42B7-837C-B8DAED299A13 Q40144352-B451C67C-BC0B-40D5-BDB6-0041E54A50F3 Q40478509-3F96C8B8-1ACF-47E9-9F42-7641BA7CE720 Q40907155-41AEA882-701F-41C1-A3F8-E8FB044BE7A5 Q40955862-573D653C-46D7-4F9B-915F-EC0B7833E9F2 Q41232974-F7BF7233-DFBA-4F1F-8048-9C1C19EBD640 Q41598140-28F48879-E31C-49BF-8F99-0C9B361AB03D Q44356753-379A50C9-CAFA-480F-AD0B-895D51DC1144 Q44883574-6F684E1D-5E43-4D92-AD39-711876AE9766 Q50628385-404F057E-8C60-4E30-8075-8EE253773EE1 Q51475336-F065F916-042E-48D2-B965-1331C240B053

P2860

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

http://www.wikidata.org/entity/Q34213612

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

@ast

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

@en

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

@nl

type

label

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

@ast

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

@en

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

@nl

prefLabel

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

@ast

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

@en

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

@nl

P1433

Q34213612-0E9A0BD8-C55A-458B-8CD8-9AF8D1FC04BF

P1476

Q34213612-83ABAB42-092A-4002-818E-BA302E214920

P2093

Q34213612-2FD04C60-D125-4066-B1E3-278F507ADE9C

Q34213612-8489DE52-9A1E-44A0-B2D6-C9F142C8D659

Q34213612-AE893E43-229E-4DB7-987F-3A00EED85677

Q34213612-AF98D212-CFED-4A00-82FA-7D815850430E

Q34213612-FF6F5142-8E97-43D0-8CFB-5224FAFA19AA

P2860

Q34213612-0031EED2-8ADD-46F9-8531-6DC13F906AF2

Q34213612-0DCEA1F2-17C2-4A01-872B-46F3977281C2

Q34213612-18AD3C37-0092-428E-92F1-A84BB6CB8F0F

Q34213612-1AFF5D37-8304-4E02-8455-272D22DB7784

Q34213612-1F7E2DFA-2CB1-4E6F-B778-FFD7BEC85B53

Q34213612-28E5F61E-7FCE-4FEE-8921-E9522AEB295C

Q34213612-2B9BD24D-F527-4D8C-938B-9456F6D2829E

Q34213612-3583BCA9-C484-4C65-9809-BD6D86591256

Q34213612-3BEDE812-2907-4ED5-A41D-3D289E0FBD4F

Q34213612-575E8911-D8C2-4292-AA92-BAA8145E6FCE

P2888

Q34213612-2A740BA9-0557-4843-A93A-153BD27105BA

P304

Q34213612-5B8D44BB-3B04-45BF-B645-20C7F70E258D

P31

Q34213612-F3B80ACE-3E3F-4F0B-AE37-23D2BB83C995

P356

Q34213612-672DDADD-FAB3-41D5-B134-AFB196ACA08F

P433

Q34213612-B0DD5415-6C7E-4A76-A59D-8B8D71537B35

P478

Q34213612-343AA2D5-0ACE-4C26-A3D2-D88226F1FC9F

P577

Q34213612-AC9AEE9C-50CF-4BE5-9A8F-CCF35C5CF711

P5875

Q34213612-58BAF077-1D15-4141-B971-E4A8AFEBC851

P6179

Q34213612-E255E94E-E559-4487-8E31-64C5A1323F2F

P698

Q34213612-E6EB5FB2-5B56-4F79-8FDA-0A4F95E49BBE

P921

Q34213612-63F527FA-D035-4C95-B80C-9883EB107BD9

Q34213612-D82A6C82-7F98-4842-B119-42AEACE57577

P932

Q34213612-F2D0F902-C49E-44B0-97C5-99F6991A5804

P356

S00228-010-0865-7

P1433

European Journal of Clinical Pharmacology

P1476

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

@en

P2093

Anneke Passier

http://www.w3.org/2001/XMLSchema#string

Christine van der Welle

http://www.w3.org/2001/XMLSchema#string

Eugène van Puijenbroek

http://www.w3.org/2001/XMLSchema#string

Florence van Hunsel

http://www.w3.org/2001/XMLSchema#string

Kees van Grootheest

http://www.w3.org/2001/XMLSchema#string

P2860

Why, and how, mixed methods research is undertaken in health services research in England: a mixed methods study.

Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom.

The missing voice of patients in drug-safety reporting.

Reasons for reporting adverse drug reactions--some thoughts based on an international review.

Patients' role in reporting adverse drug reactions.

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

Attitudinal survey of voluntary reporting of adverse drug reactions

Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example

Determinants of under-reporting of adverse drug reactions: a systematic review.

Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.

P2888

s00228-010-0865-7

P304

1143-1150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-010-0865-7

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45289001

http://www.w3.org/2001/XMLSchema#string

P6179

1053612241

http://www.w3.org/2001/XMLSchema#string

P698

20658130

http://www.w3.org/2001/XMLSchema#string

P921

P932

2957580

http://www.w3.org/2001/XMLSchema#string